Provider review
LVNG RX review
Markets flat, transparent pricing on every page and publishes none of it.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
We may earn a commission at no extra cost to you. Affiliate partners are listed first on our rankings. How we’re funded.
Microdose price not published
Visit LVNG RXThe named microdose protocol carries no figure at any tier, and the bundle ships prices higher than the ones the page shows.
Price as published
LVNG RX
Microdose price not published
- Vs median
- Not comparable — no figure is published before intake
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- No low-dose price published
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
The clinical framing is genuinely well done: a separate microdose protocol with its own page, an explicit non-weight-loss goal, published exclusions, and trial figures attributed to the trials rather than claimed as outcomes. The pricing is the opposite. Every treatment page advertises flat transparent pricing and publishes no price on that page, the microdose has no figure at any tier, and a second, hidden set of prices built into the site is higher than the struck-through numbers the homepage displays. A third figure appears in an on-page widget that matches no tier the site describes.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want a microdose protocol framed around body composition and metabolic health rather than weight loss
- You want clinical exclusions published on the treatment page rather than buried in terms
- You are willing to complete an eligibility quiz to learn any price at all
Look elsewhere if
- You want to cost the microdose against anything, because no figure is published for it
- You want the price on the page to be the price the platform holds internally, which it is not
- You want a named pharmacy or a stated compounding designation
What it actually costs
Price as published
Microdose price not published
- Vs median
- Not comparable — no figure is published before intake
- Market
- $59–$1,300/mo is the full published spread on this site
- Structure
- No low-dose price published
A low-dose lane may exist, but nothing public says what it costs — so the one question this page exists to answer cannot be answered before you sign up.
78 of the 548 programs here price a small dose this way. Its named GLP-1 Microdose protocol shows no price at any level, on a site whose every treatment page markets flat, transparent pricing while publishing none. A second, higher set of prices sits hidden behind the displayed ones, and a third figure in an on-page widget matches no plan the site describes.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not confirmed
- Labs
- Not required
- Pricing
- Check plan terms
What it does well
- Runs a genuinely separate, clinically framed GLP-1 Microdose protocol with its own treatment page rather than a low starting dose of the weight-loss program
- The microdose page states an explicit non-weight-loss goal — body composition, metabolic health and appetite recalibration rather than aggressive weight loss
- The homepage cards state exactly what the price includes: provider visit, prescription, home delivery and ongoing check-ins
- Clinical exclusions are published on each treatment page rather than buried in terms
- Cites its trial sources by name rather than presenting a published trial figure as its own outcome
- The legal entity is named plainly in the terms of use
Pharmacy, labs and oversight
LVNG RX does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
1 of 4 published openly
What LVNG RX publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere on its own pages.
- Not published
- A price you can read before intakeThe figure appears only after an intake quiz, so it cannot be compared before signing up.
- Not published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
LVNG RX is operated by LVNG RX LLC, which per its own terms owns the site and acts as a technology platform connecting patients to an unnamed medical group, providers and pharmacies. It sells three GLP-1 programs — semaglutide, tirzepatide and a GLP-1 Microdose protocol positioned around body composition and longevity rather than weight loss — plus combination protocols reachable from the eligibility funnel. Care is telehealth-only and entry is through a quiz that gates all pricing behind provider review. No pharmacy is named anywhere on the site, no 503A or 503B designation is stated, and states are described only as nationwide telehealth.
The honest cons
Every treatment page markets flat, transparent pricing and no hidden fees while publishing no price whatsoever on that page — the GLP-1 Microdose has no figure at any tier, so the one product this site would send a reader here for cannot be cost-compared against anything
- Hidden prices for all three programs, built into the page but never shown, are higher than the struck-through figures the homepage displays, so two different price sets sit inside the same page
- A third figure appears in the on-page BMI widget that is purchasable at no tier the site describes and undercuts the site's own headline card
- No pharmacy is named anywhere, and no 503A or 503B designation is stated
- The homepage renders live-looking statistic counters that sit at zero in the served HTML
- No milligram figure appears anywhere on the site for any product
- Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
LVNG RX is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.
Also consider
Two more programs that price a small dose the way LVNG RX does. Both are partners: we may earn a commission if you start care through these links.
Partner
HumeCare+
$199–$299/mo (gated)
No low-dose price published
Partner
Wellorithm
Compounded line not published · brand pens priced
No low-dose price published
Where this sits
#65 of 548
Ordered with the companies that pay us first, and LVNG RX is not one of them. A disclosed partition, not a score.
Compare all 548 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What the evidence actually shows
- What microdosing GLP-1 costs
- Who should not microdose
- The true annual cost of a plan
- What a flat price costs at a low dose
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
Oak
$250–$300/mo
- Vs median
- $75/mo above the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- No low-dose price published
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the Oak review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.